| JYSZ2400002 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | License Renew | 2024-01-03 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSZ2400001 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | License Renew | 2024-01-03 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2500039 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2025-02-15 | | Astrazeneca Uk Ltd | | | view |
| JYSB2500038 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2025-02-15 | | Astrazeneca Uk Ltd | | | view |
| JYSB2300139 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-08-17 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2300138 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-08-17 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2300122 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-07-14 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2300121 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-07-14 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2300055 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-03-22 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2300054 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-03-22 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2200177 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-09-10 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2200176 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-09-10 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2200078 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2200077 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2200071 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-19 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2200070 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-19 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2100016 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-01-12 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Filed | 2021-01-22 | view |
| JYSB2100015 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-01-12 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Filed | 2021-01-22 | view |
| JYSB2000600 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2021-03-15 | view |
| JYSB2000599 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Approval Completed-Pending Certificated | 2021-08-20 | view |
